Expansion of tumor infiltrating lymphocytes (TIL) from bladder cancer

Advanced bladder cancer patients have limited therapeutic options resulting in a median overall survival (OS) between 12 and 15 months. Adoptive cell therapy (ACT) using tumor infiltrating lymphocytes (TIL) has been used successfully in treating patients with metastatic melanoma, resulting in a medi...

Descripción completa

Detalles Bibliográficos
Autores principales: Poch, Michael, Hall, MacLean, Joerger, Autumn, Kodumudi, Krithika, Beatty, Matthew, Innamarato, Pasquale P., Bunch, Brittany L., Fishman, Mayer N., Zhang, Jingsong, Sexton, Wade J., Pow-Sang, Julio M., Gilbert, Scott M., Spiess, Philippe E., Dhillon, Jasreman, Kelley, Linda, Mullinax, John, Sarnaik, Amod A, Pilon-Thomas, Shari
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2018
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6140546/
https://www.ncbi.nlm.nih.gov/pubmed/30228944
http://dx.doi.org/10.1080/2162402X.2018.1476816

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6140546/
https://www.ncbi.nlm.nih.gov/pubmed/30228944
http://dx.doi.org/10.1080/2162402X.2018.1476816

Ejemplares similares